Osteocalcin (GLA protein) is the primary non-collagenous protein in bone tissue, playing a key role in calcium and hydroxyapatite binding. It is synthesized by osteoblasts and odontoblasts and consists of 49 amino acids, with a molecular weight of approximately 5800 Da.
Clinical Significance of Osteocalcin
- Osteocalcin is a sensitive marker of bone metabolism.
- Its blood concentration reflects osteoblastic activity, as osteocalcin in the bloodstream results from new synthesis rather than bone resorption.
- It is believed to play a role in regulating calcium absorption.
- High osteocalcin levels correlate with increased bone resorption, making it a useful indicator of bone turnover and metabolic bone diseases.
Regulatory Factors
- Osteocalcin is vitamin K-dependent.
- Calcium directly influences the synthesis of regulatory hormones, including:
- Calcitonin
- Parathyroid hormone (PTH)
- Vitamin D
- Other regulatory factors affecting osteoblast activity
Biomaterial: Venous blood
Pre-test recommendations:
- Fasting for 12 hours before the test
- Discontinuation of medications 24 hours before the test (under medical supervision)
- Diagnosis of osteoporosis
- Monitoring antiresorptive therapy in osteoporosis patients
- Hypercalcemic syndrome
- Recommended in combination with deoxypyridinoline (DPD) testing for a more comprehensive assessment of bone metabolism
Artması:
- postmenopozal osteoporoz;
- osteomalasiya;
- Birincil və ikincil hiperparatireoz;
- Paget xəstəliyi;
- böyrək osteodistrofiyası;
- Şişlər, sümük metastazları;
- Diffuz zəhərli guatr;
- yeniyetmələrdə sürətli böyümə;
- Xroniki böyrək çatışmazlığı.
Azalması:
- Hiperkortizolizm (İtsenko-Cushing xəstəliyi və sindromu);
- Glukokortikoid hormon terapiyası;
- hipoparatireoz;
- Birincili biliyer siroz;
- Hamiləlik;
- Böyümə hormonu çatışmazlığı.